RIGScan CR49 data

NEOP said preliminary analysis of its Phase III trial with RIGScan suggest that the data are consistent with data from its Phase II study, which showed the product was able to help surgeons detect otherwise hidden tumor during surgery.

The Phase III results will be presented at the Society of Surgical Oncology meeting, March 21-24, 1996. ...